TRIAZOLAM - AN OVERVIEW

Coadministration with CYP3A4 substrates, specially All those having a slender therapeutic index, can lead to lessened concentrations and lack of efficacy. If unable to steer clear of coadministration, keep track of CYP3A4 substrate amounts and change dose as wanted.Reserve concomitant prescribing of such medicines in people for whom other treatment